¥2,094.00
0.34% yesterday
Tokyo, Dec 25, 07:12 am CET
ISIN
JP3428850006
Symbol
4559

Zeria Pharmaceutical Stock price

¥2,099.00
+88.00 4.38% 1M
+28.00 1.35% 6M
-343.00 14.05% YTD
-309.00 12.83% 1Y
-132.00 5.92% 3Y
+188.00 9.84% 5Y
+581.00 38.27% 10Y
+1,077.18 105.42% 20Y
Tokyo, Closing price Thu, Dec 25 2025
+12.00 0.58%
ISIN
JP3428850006
Symbol
4559
Industry

Key metrics

Basic
Market capitalization
¥91.2b
Enterprise Value
¥108.3b
Net debt
¥17.2b
Cash
¥22.7b
Shares outstanding
44.1m
Valuation (TTM | estimate)
P/E
16.4 | 13.2
P/S
1.1 | 1.0
EV/Sales
1.3 | 1.2
EV/FCF
25.7
P/B
1.0
Dividends
DPS
¥48.00
Yield 1Y | 5Y
2.3% | 2.0%
Growth 1Y | 5Y
2.1% | 7.1%
Payout 1Y | 3Y
20.9% | 24.2%
Increased
5 Years
Financials (TTM | estimate)
Revenue
¥84.8b | ¥90.9b
EBITDA
¥16.7b | ¥17.4b
EBIT
¥9.4b | -
Net Income
¥5.6b | ¥7.0b
Free Cash Flow
¥4.2b
Growth (TTM | estimate)
Revenue
4.2% | 4.1%
EBITDA
-8.1% | -3.7%
EBIT
-8.7% | -
Net Income
-33.1% | -29.9%
Free Cash Flow
-68.7%
Margin (TTM | estimate)
Gross
72.8%
EBITDA
19.7% | 19.1%
EBIT
11.1%
Net
6.6% | 7.7%
Free Cash Flow
5.0%
Financial Health
Equity Ratio
56.3%
Return on Equity
11.1%
ROCE
8.9%
ROIC
5.8%
Debt/Equity
0.4
More
EPS
¥127.3
FCF per Share
¥95.6
Short interest
-
Employees
2k
Rev per Employee
¥49.1m
Show more

Is Zeria Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Zeria Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Zeria Pharmaceutical forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Zeria Pharmaceutical forecast:

Buy
80%
Hold
20%

Financial data from Zeria Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
84,849 84,849
4% 4%
100%
- Direct Costs 23,112 23,112
5% 5%
27%
61,737 61,737
4% 4%
73%
- Selling and Administrative Expenses 52,358 52,358
7% 7%
62%
- Research and Development Expense - -
-
-
16,710 16,710
8% 8%
20%
- Depreciation and Amortization 7,331 7,331
7% 7%
9%
EBIT (Operating Income) EBIT 9,379 9,379
9% 9%
11%
Net Profit 5,613 5,613
33% 33%
7%

In millions JPY.

Don't miss a Thing! We will send you all news about Zeria Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,777 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Head office Japan
Employees 1,777
Website www.zeria.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today